Clinical trial
Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
NCT07773272 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
- Lead sponsor
- Zuyderland Medisch Centrum
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 16, 2026
- Completion date
- March 31, 2029
- Enrollment
- 1,215 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome (acs) undergoing percutaneous coronary intervention (pci), cardiovascular risk management, diabete mellitus, hypercholerolemia, hypertension